Not everyone with a fatty liver goes on to develop more advanced disease. Understanding what triggers the progression could lead to better treatments.
This is a preview of subscription content, log in via an institution to check access.
Additional information
This article is part of Nature Outlook: Fatty liver disease, an editorially independent supplement produced with the financial support of third parties. About this content.
Rights and permissions
About this article
Cite this article
DeWeerdt, S. Disease progression: Divergent paths. Nature 551, S92–S93 (2017). https://doi.org/10.1038/d41586-017-06925-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/d41586-017-06925-2
- Springer Nature Limited